Axogen Inc (AXGN) is a Healthcare · Medical Devices company listed on NASDAQ. Price $44.23 (-2.33%), Market cap $2.17B, 52-week low–high $9.29 ~ $43.74.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard
Financial statements, price targets, institutional (13F) holdings and related news for Axogen Inc are updated in real time on BlackAll Trade.
Axogen Inc trades at $44.23 (-2.33%). Real-time quotes and charts are available on BlackAll Trade.
Axogen Inc has a market cap of about $2.17B.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avanc